C12h21n5o3

Introduction

C12H21N5O3 is a molecular formula that can represent a variety of organic compounds, including heterocyclic structures, nucleoside analogues, and certain pharmaceutical agents. The combination of twelve carbon atoms, twenty-one hydrogen atoms, five nitrogen atoms, and three oxygen atoms suggests the presence of a heteroaromatic ring system fused with a sugar moiety or a nucleobase attached to a carbon chain. This formula is commonly encountered in medicinal chemistry, particularly in the design of antiviral and anticancer agents that target nucleic acid synthesis. Because of its potential biological relevance, a detailed examination of the structural, physicochemical, and pharmacological aspects of compounds bearing this empirical formula is warranted.

Chemical Composition and Formula

Empirical Representation

The empirical formula C12H21N5O3 conveys the stoichiometric proportions of the constituent elements but does not provide information on connectivity or stereochemistry. For compounds with this formula, possible structural frameworks include pyrimidine or purine bases attached to ribose or deoxyribose analogues, as well as aliphatic chains with amide or amine linkages. The presence of five nitrogen atoms often indicates the inclusion of a heterocyclic base such as adenine, guanine, or cytosine, while the three oxygen atoms typically correspond to hydroxyl groups or carbonyl functionalities.

Atomic Properties

Carbon atoms in such molecules are sp² hybridized within aromatic rings and sp³ hybridized in aliphatic chains or sugar moieties. Hydrogen atoms are primarily bonded to carbon, nitrogen, or oxygen, reflecting the saturated or unsaturated nature of the structure. Nitrogen atoms may participate in tautomeric forms, influencing basicity and hydrogen-bonding capacity. Oxygen atoms, being highly electronegative, contribute to polar solubility and can participate in hydrogen bonding as donors or acceptors.

Structural Possibilities

Purine-Based Frameworks

In many nucleoside analogues, a purine base such as adenine (C5H5N5) is fused to a pentose sugar. The formula C12H21N5O3 can accommodate an adenine moiety (C5H5N5) combined with a deoxy-ribose skeleton (C7H12O3), resulting in a nucleoside with a single oxygen atom at the anomeric position replaced by a nitrogen atom or a carbonyl group. This arrangement is typical of nucleoside reverse transcriptase inhibitors (NRTIs) used in antiviral therapy.

Pyrimidine-Based Frameworks

Alternatively, a pyrimidine base such as cytosine (C4H5N3O) or uracil (C4H4N2O2) can be linked to a modified sugar or an aliphatic side chain. For example, a cytosine base combined with a deoxy-ribose analog and a carbonyl group yields a compound matching the C12H21N5O3 formula. These structures are often employed as DNA synthesis inhibitors or as probes in nucleic acid research.

Aliphatic and Cyclic Derivatives

Beyond nucleoside analogues, the formula may correspond to cyclic compounds featuring a six-membered ring containing nitrogen atoms, such as triazines or triazolopyrimidines. When attached to an aliphatic chain bearing hydroxyl groups, these structures can adopt conformations that enhance membrane permeability and metabolic stability.

Synthesis Methods

Condensation Reactions

One common synthetic route involves the condensation of a suitable aldehyde or ketone with a heterocyclic amine under acidic or basic conditions. For nucleoside analogues, a base-catalyzed condensation between a ribose derivative and an imidazole or triazole base yields the glycosidic bond. Subsequent protection-deprotection steps, such as acetylation of hydroxyl groups followed by deprotection, refine the functional groups to the desired pattern.

Reductive Amination

Reductive amination is frequently employed to introduce nitrogen atoms into a carbonyl-containing scaffold. By reacting an aldehyde or ketone with an amine in the presence of a reducing agent like sodium cyanoborohydride, a secondary or tertiary amine can be formed. This method is advantageous for installing the nitrogen atoms in a controlled stereochemical environment.

Phosphoramidite Chemistry

In the synthesis of nucleoside analogues, phosphoramidite chemistry enables the formation of phosphodiester linkages with high yield and stereospecificity. This technique is especially useful when the final compound contains a phosphate group, as seen in many nucleotide-based drugs.

Modern Catalytic Approaches

Transition-metal-catalyzed cross-coupling reactions, such as Suzuki–Miyaura or Buchwald–Hartwig amination, provide efficient pathways for constructing carbon–nitrogen bonds. When applied to heterocyclic substrates, these reactions can install aryl or alkyl groups that contribute to the overall carbon skeleton, thereby achieving the C12 backbone.

Physical and Chemical Properties

Solubility

Compounds with the C12H21N5O3 formula exhibit moderate water solubility due to the presence of multiple hydrogen-bonding sites. The balance between hydrophilic and lipophilic groups influences the solubility profile: increasing the number of hydroxyl groups or adding polar substituents typically enhances aqueous solubility, while alkyl chains or aromatic rings reduce it.

Melting Point and Boiling Point

Melting points for nucleoside analogues within this formula range from 120 °C to 210 °C, depending on crystallinity and hydrogen-bonding networks. Boiling points are generally above 400 °C under reduced pressure, reflecting the high molecular weight and the presence of strong intermolecular forces.

Optical Activity

Many derivatives possess chiral centers, particularly at the anomeric carbon of the sugar moiety or at side-chain stereocenters. Optical rotation measurements reveal enantiomeric purity and can be used to confirm stereochemical assignments. In drug development, the biologically active enantiomer is typically isolated or synthesized enantioselectively.

Spectroscopic Signatures

Infrared (IR) spectra show characteristic bands for N–H (3300 cm⁻¹), O–H (3400 cm⁻¹), and C=O stretching (1650–1700 cm⁻¹).
¹H NMR spectra display multiplets for aromatic protons (7–8 ppm) and singlets for sugar protons (3–5 ppm).
¹³C NMR spectra reveal signals for carbonyl carbons (170–180 ppm), aromatic carbons (120–150 ppm), and aliphatic carbons (10–80 ppm).
Mass spectrometry typically shows a molecular ion peak at m/z = 241 for the protonated molecule, with fragmentation patterns indicative of loss of hydroxyl or amine groups.

Applications in Medicine and Biology

Antiviral Agents

Several antiviral drugs incorporate the C12H21N5O3 formula or closely related analogues. These agents often function as nucleoside reverse transcriptase inhibitors (NRTIs), interfering with viral DNA synthesis by acting as chain terminators. By mimicking natural nucleosides, they are incorporated into viral DNA and prevent further elongation. The potency of such compounds depends on their ability to be phosphorylated by cellular kinases and to fit into the active site of reverse transcriptase.

Anticancer Drugs

In oncology, nucleoside analogues with this empirical formula can inhibit ribonucleotide reductase or DNA polymerases, leading to stalled replication forks and apoptosis. Certain formulations are combined with other chemotherapeutic agents to enhance efficacy and reduce resistance. The selectivity for rapidly dividing cells arises from the higher demand for nucleotides in cancerous tissues.

Biological Probes

Fluorescent or radiolabeled analogues are employed as probes to study nucleic acid metabolism, transport, and enzymatic pathways. Their incorporation into DNA or RNA allows visualization of replication dynamics or assessment of enzyme kinetics. The presence of functional groups amenable to conjugation facilitates the attachment of fluorophores or click chemistry handles.

Diagnostic Imaging

Compounds derived from the C12H21N5O3 skeleton are also used in positron emission tomography (PET) or single-photon emission computed tomography (SPECT) imaging. By labeling with isotopes such as ¹⁸F or ¹⁸F, they can serve as tracers for measuring metabolic activity in tissues, providing insights into disease states like viral infections or tumor progression.

Vaccinology

Modified nucleosides can improve the stability and immunogenicity of nucleic acid vaccines. By incorporating analogues that reduce innate immune activation while preserving translation efficiency, vaccine platforms such as mRNA therapies can achieve higher protein yields and lower reactogenicity.

Pharmacological Properties

Mechanism of Action

The core pharmacological action involves incorporation into nucleic acid strands or competition with natural nucleotides for enzymatic processing. For reverse transcriptase inhibitors, the 3'-hydroxyl group is either missing or replaced by a non-labile moiety, preventing further nucleotide addition. For anticancer analogues, the inhibition of ribonucleotide reductase reduces the pool of deoxynucleotides, leading to DNA damage.

Pharmacokinetics

Oral bioavailability varies with the degree of hydrogen bonding and lipophilicity. Compounds with moderate lipophilicity (log P between 0.5 and 2.5) exhibit good absorption. First-pass metabolism by hepatic enzymes, especially CYP3A4, can reduce systemic exposure. Prodrug strategies, such as phosphate esterification, improve plasma stability and allow for controlled release.

Drug–Drug Interactions

Inhibition or induction of cytochrome P450 enzymes can alter the plasma levels of co-administered medications. For example, concomitant use of strong CYP3A4 inhibitors may increase the concentration of the active metabolite, raising the risk of toxicity. Conversely, CYP3A4 inducers may reduce efficacy by accelerating metabolism.

Resistance Mechanisms

Viral mutations in the polymerase active site can reduce binding affinity for analogues, leading to resistance. In cancer cells, upregulation of drug efflux pumps such as P-glycoprotein may lower intracellular concentrations. Combination therapy with agents targeting resistance pathways mitigates these effects.

Toxicological Aspects

Acute Toxicity

In animal studies, acute toxicity assessments (LD₅₀) have shown values ranging from 200 mg/kg to >1000 mg/kg, depending on the formulation and route of administration. Symptoms of acute toxicity include gastrointestinal upset, lethargy, and hepatotoxicity.

Chronic Exposure

Long-term administration may lead to bone marrow suppression, hepatotoxicity, or nephrotoxicity. Monitoring of complete blood counts and liver function tests is recommended during treatment. Dose adjustments based on renal or hepatic impairment help avoid cumulative toxicity.

Reproductive and Developmental Toxicity

Studies in rodents have indicated potential teratogenic effects at high doses. The presence of nitrogen-rich heterocycles may interfere with DNA replication during embryogenesis, leading to malformations. As a result, contraindications are in place for use during pregnancy unless benefits outweigh risks.

Carcinogenicity

Chronic exposure to certain nucleoside analogues has been associated with an increased risk of secondary malignancies, particularly lymphomas, in specific patient populations. The mechanism involves incorporation into host DNA, leading to mutagenic lesions. Surveillance protocols are advised for long-term users.

Regulatory Status

Approved Therapeutic Uses

Several agents incorporating the C12H21N5O3 core have received approval from regulatory agencies such as the FDA and EMA. Indications include treatment of HIV infection, hepatitis B, and certain cancers. Approval documents specify dosing regimens, contraindications, and monitoring requirements.

Investigational New Drug (IND) Applications

New analogues designed to improve potency or reduce side effects undergo preclinical safety studies followed by IND filings. Phase I trials focus on pharmacokinetics and safety in healthy volunteers, while Phase II and III trials assess efficacy in target disease populations.

Patent Landscape

The chemical space defined by C12H21N5O3 is subject to numerous patents covering synthesis methods, prodrug formulations, and combination therapies. Patent claims often involve specific substitution patterns on the heterocycle or sugar moiety that confer improved pharmacokinetic profiles.

Fluorinated Analogues

Incorporation of fluorine atoms into the ring system increases metabolic stability and enhances binding affinity to target enzymes. Fluorinated nucleoside analogues retain the empirical formula while altering electronic properties.

Phosphoramidate Prodrugs

Adding a phosphoramidate moiety improves oral bioavailability by bypassing initial phosphorylation steps. This strategy, exemplified by so-called "ProTide" technology, yields higher intracellular concentrations of the active monophosphate.

Conjugated Delivery Systems

Linking the core compound to lipid or polymer carriers facilitates targeted delivery to specific tissues, such as the liver or tumors. Conjugates may exploit receptor-mediated endocytosis to increase cellular uptake.

Analytical Methods

Chromatographic Techniques

High-performance liquid chromatography (HPLC) coupled with UV or fluorescence detection is standard for quantifying drug levels in plasma.
Liquid chromatography–mass spectrometry (LC–MS) provides sensitive identification of metabolites and degradation products.
Gas chromatography–mass spectrometry (GC–MS) is employed after derivatization to analyze volatile fragments.

Spectrophotometric Assays

UV–Vis spectrophotometry monitors the characteristic absorbance of the nucleobase at 260 nm, allowing assessment of purity during synthesis.

Enzymatic Assays

Phosphorylation kinetics are measured using kinase assays that track conversion of the parent compound to its triphosphate form. Polymerase inhibition assays evaluate incorporation efficiency.

In vivo Imaging

Positron emission tomography (PET) quantifies uptake in target tissues, while autoradiography confirms distribution patterns in ex vivo samples.

Future Directions

Precision Medicine

Genomic profiling of patients may identify polymorphisms that predict response or resistance to C12H21N5O3 derivatives. Personalized dosing regimens based on genetic markers could improve therapeutic outcomes.

Combination with Immune Modulators

Integrating analogues with checkpoint inhibitors or immunomodulators may enhance anti-tumor activity. Early-stage trials evaluate synergy and tolerability.

CRISPR–Based Applications

Modified nucleosides can improve the fidelity and delivery of CRISPR guide RNAs, expanding genome editing capabilities. Chemical modifications reduce off-target effects and increase editing efficiency.

Nanomedicine Integration

Encapsulation within nanoparticles allows for controlled release and reduced systemic exposure. Emerging platforms investigate biodegradable polymers that release the core analogue in response to tumor microenvironment cues.

Conclusion

The C12H21N5O3 empirical formula defines a versatile class of nitrogen-rich heterocycles with multiple applications across antiviral, anticancer, and diagnostic fields. Its structural features enable mimicry of natural nucleosides, providing a foundation for potent enzyme inhibition and cellular uptake. Ongoing research seeks to refine pharmacological profiles, mitigate toxicity, and overcome resistance, ensuring that these compounds continue to play a significant role in modern therapeutics.

Search

Table of Contents